Results 101 to 110 of about 1,026,457 (302)

The Quest for a Truly Universal Influenza Vaccine

Frontiers in Cellular and Infection Microbiology, 2019
There is an unmet public health need for a universal influenza vaccine (UIV) to provide broad and durable protection from influenza virus infections. The identification of broadly protective antibodies and cross-reactive T cells directed to influenza ...
Y. Jang, B. Seong
semanticscholar   +1 more source

Roadblocks to translational challenges on viral pathogenesis. [PDF]

, 2013
Distinct roadblocks prevent translating basic findings in viral pathogenesis into therapies and implementing potential solutions in the clinic. An ongoing partnership between the Volkswagen Foundation and Nature Medicine resulted in an interactive ...
Deeks, Steven, Drosten, Christian, Picker, Louis, Subbarao, Kanta, Suzich, Joann   +4 more
core   +1 more source

Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season.

PLoS ONE, 2013
IntroductionThe 2011-12 trivalent influenza vaccine contains a strain of influenza B/Victoria-lineage viruses. Despite free provision of influenza vaccine among target populations, an epidemic predominated by influenza B/Yamagata-lineage viruses occurred
Yi-Chun Lo, Jen-Hsiang Chuang, Hung-Wei Kuo, Wan-Ting Huang, Yu-Fen Hsu, Ming-Tsan Liu, Chang-Hsun Chen, Hui-Hsun Huang, Chi-Hsi Chang, Jih-Haw Chou, Feng-Yee Chang, Tzou-Yien Lin, Wen-Ta Chiu   +12 more
doaj   +1 more source

Coverage of influenza vaccination and influencing factors among healthcare workers in Shandong Province, China, 2021–2022

Human Vaccines & Immunotherapeutics
Healthcare workers (HCWs) are at increased risk of exposure to the influenza virus in their daily clinical and disease prevention activities, making them a high-risk group for influenza infection.
Yuwei Liu, Ti Liu, Mingxiao Yao, Qiang Wang, Renpeng Li, Zengqiang Kou   +5 more
doaj   +1 more source

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018

MMWR. Morbidity and mortality weekly report, 2018
In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months (1). During each influenza season since 2004-05, CDC has estimated the effectiveness of seasonal influenza vaccine to prevent laboratory ...
B. Flannery, J. Chung, E. Belongia, H. McLean, M. Gaglani, Kempapura Murthy, Richard K. Zimmerman, M. Nowalk, Michael L. Jackson, Lisa A. Jackson, A. Monto, Emily T. Martin, Angie Foust, W. Sessions, L. Berman, John R. Barnes, Sarah M. Spencer, Alicia M. Fry   +17 more
semanticscholar   +1 more source

Mapping trends and hotspots in research on global influenza vaccine hesitancy: A bibliometric analysis

Health Science Reports
Background and Aims Influenza is one of the most widespread respiratory infections and poses a huge burden on health care worldwide. Vaccination is key to preventing and controlling influenza.
Zhengyu Zhang, Songjia Tang, Zhihui Huang, Juntao Tan, Xiaoxin Wu, Qian Hong, Yuan Yuan   +6 more
doaj   +1 more source

A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand

Human Vaccines & Immunotherapeutics, 2019
Being vigilant of the potential for an influenza pandemic, the Global Action Plan for Influenza Vaccines (GAP) promoted the establishment and maintenance of local vaccine manufacturing capacity.
Punnee Pitisuttithum, Ponthip Wirachwong
doaj   +1 more source

Pandemic Influenza Vaccines [PDF]

, 2009
Since their compositions remain uncertain, universal pandemic vaccines are yet to be created. They would aim to protect globally against pandemic influenza viruses that have not yet evolved. Thus they differ from seasonal vaccines to influenza virus, which are updated annually in spring to incorporate the latest circulating viruses, and are then ...
Lauren J. DiMenna, Hildegund C. J. Ertl
openaire   +3 more sources

Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness

npj Vaccines, 2018
The 2017–2018 seasonal influenza epidemics were severe in the US and Australia where the A(H3N2) subtype viruses predominated. Although circulating A(H3N2) viruses did not differ antigenically from that recommended by the WHO for vaccine production ...
I. Barr, R. Donis, J. Katz, J. McCauley, T. Odagiri, H. Trusheim, T. Tsai, D. Wentworth   +7 more
semanticscholar   +1 more source

Novel Platforms for the Development of a Universal Influenza Vaccine

Frontiers in Immunology, 2018
Despite advancements in immunotherapeutic approaches, influenza continues to cause severe illness, particularly among immunocompromised individuals, young children, and elderly adults.
A. Kumar, T. Meldgaard, S. Bertholet
semanticscholar   +1 more source